Results 211 to 220 of about 161,535 (242)
Some of the next articles are maybe not open access.
International Journal of Technology Assessment in Health Care, 1994
AbstractIt has been 20 years since the concepts that are now embraced in the term recombinant DNA technology were first described. The technology has been used to design new vaccines, and one product — that for hepatitis B — has been in widespread use for almost a decade.
openaire +2 more sources
AbstractIt has been 20 years since the concepts that are now embraced in the term recombinant DNA technology were first described. The technology has been used to design new vaccines, and one product — that for hepatitis B — has been in widespread use for almost a decade.
openaire +2 more sources
2003
Vaccination has relied, in general, on two technologies for the production of antigenic material suitable for the generation of a protective immune response; live infectious agents and inactivated or subunit vaccine preparations. Live infectious agents generally are most efficacious, but there is always a risk factor when using this type of vaccine ...
S, van Drunen Littel-van den Hurk +2 more
openaire +2 more sources
Vaccination has relied, in general, on two technologies for the production of antigenic material suitable for the generation of a protective immune response; live infectious agents and inactivated or subunit vaccine preparations. Live infectious agents generally are most efficacious, but there is always a risk factor when using this type of vaccine ...
S, van Drunen Littel-van den Hurk +2 more
openaire +2 more sources
Vaccine, 2002
DNA vaccines have been the subjects of much effort over the past decade due to their ability to induce broad-based immune responses and protection in various animal models of infectious and non-infectious diseases. In particular, influenza DNA vaccines have been well studied.
openaire +2 more sources
DNA vaccines have been the subjects of much effort over the past decade due to their ability to induce broad-based immune responses and protection in various animal models of infectious and non-infectious diseases. In particular, influenza DNA vaccines have been well studied.
openaire +2 more sources
Scandinavian Journal of Infectious Diseases, 2001
DNA vaccines have been the subject of intense investigation for the past 10 y, during which time several tuberculosis (TB) DNA vaccines have been shown to confer protective immunity in animal models. So far, proof of principle for priming of immune responses by a naked DNA vaccine (malaria) has been demonstrated in humans, but potency remains a ...
openaire +2 more sources
DNA vaccines have been the subject of intense investigation for the past 10 y, during which time several tuberculosis (TB) DNA vaccines have been shown to confer protective immunity in animal models. So far, proof of principle for priming of immune responses by a naked DNA vaccine (malaria) has been demonstrated in humans, but potency remains a ...
openaire +2 more sources
Methods to improve the immunogenicity of plasmid DNA vaccines
Drug Discovery Today, 2021Angela Sousa +2 more
exaly
DNA vaccines against COVID-19: Perspectives and challenges
Life Sciences, 2021Marcelo Mendonça
exaly
A Brief Review on Dna Vaccines in the Era of COVID-19
Future Virology, 2022Massoud Saidijam +2 more
exaly
DNA vaccines against Zika virus speed into clinical trials
Nature Reviews Drug Discovery, 2016Chris Morrison
exaly
DNA Vaccines — Designer Vaccines for the 21st Century
New England Journal of Medicine, 1999Robert Seder +2 more
exaly